Issue Date: September 4, 2017
Celgene and Forma extend discovery pact
Celgene will put another $195 million into Forma Therapeutics to expand their small-molecule drug discovery partnership to include targets in the areas of protein homeostasis, inflammation,immunology, and neurodegeneration. Forma is based in Watertown, Mass., with chemistry operations in Branford, Conn. The two firms established their pact in 2013 and extended it in 2014.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society